Acumen Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.67

-0.10 (-3.61%)

As of Jun 30, 10:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +732.2% upside

Low Target $18.81

Average Target $22.22

High Target $35.10

Current Price $2.67

Current
$2.67

Target
$22.22

$18.81 $22.22 avg $35.10

Scenario Analysis

Bear Case

$18.81

604.5%

Low target

Base Case

$22.22

+732.2%

Avg target

Bull Case

$35.10

+1,214.6%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$3.60

-25.8% from high

52-Week Low

$1.10

+142.7% from low

Target vs 52W High

$22.22

+517.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%